Journal Article Summary
The article investigates the effectiveness and safety of topiramate, an antiepileptic medication, as an additional treatment for infants suffering from refractory partial-onset seizures (POS). This topic is significant because managing seizures in infants can be challenging, and finding effective treatments is crucial for improving their quality of life. Refractory seizures are those that do not respond well to standard treatments, making it essential to explore new options like topiramate.
In this study, 149 infants aged between 1 and 24 months with refractory POS were randomly assigned to receive either topiramate at varying doses (5, 15, or 25 mg/kg/day) or a placebo for 20 days. The researchers measured the change in the frequency of seizures using video-EEG recordings. The results showed that there was no significant difference in the reduction of seizure rates between the highest dose of topiramate and the placebo, indicating that topiramate did not effectively reduce seizures in this population. Additionally, some side effects, such as fever and vomiting, were reported more frequently in those receiving topiramate compared to the placebo group.
The study has limitations, including the relatively small sample size and the short duration of treatment, which may affect the generalizability of the findings. While no new safety concerns were identified, the presence of side effects suggests that caregivers should be cautious when considering topiramate for their infants. It is important for parents and caregivers to discuss these findings and any concerns about seizure management with their healthcare professionals to explore the best treatment options for their child's specific needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Novotny E., Renfroe B., Yardi N., Nordli D., Ness S., Wang S., Weber T., Kurland C. L., et al.. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures. Neurology 2010. DOI: 10.1212/WNL.0b013e3181d1cd4c. PMID: 20089937. PMCID: PMC2836871.
Featured Pill Pals Product
Topiramate 100 mg Tablet --- Generic For Topamax --- Zydus Pharma
Topiramate 100 mg Tablet — Generic For Topamax — Zydus Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
